Natera, Inc.
NasdaqGS:NTRA
Sector
Location
Market Cap
USD 19.25 B
Share Price
USD 140.96
Avg Daily Volume
1,331,901
Change (1 day)
3.77%
Change (1 year)
44.20%
Change (YTD)
-10.95%
Natera, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 153.12 M
Natera, Inc. Operating Cash Flow is USD 153.12 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -210.10% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Natera, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -139.06 M, a -62.93% change year over year.
-
Natera, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -375.11 M, a -5.66% change year over year.
-
Natera, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -397.64 M, a 78.88% change year over year.
-
Natera, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -222.29 M, a 233.14% change year over year.
StockViz
Competitors
CareDx, Inc
USD 12.86
CDNA
+0.14
1.10%
Veracyte, Inc.
USD 23.97
VCYT
-0.50
-2.04%
Myriad Genetics, Inc.
USD 4.05
MYGN
-0.05
-1.22%
Castle Biosciences, Inc.
USD 16.08
CSTL
-0.15
-0.92%
Guardant Health, Inc.
USD 45.19
GH
+1.87
4.32%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|